Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DR25D1106
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 9,345 $69,200,513 obligated
Award facts
- Opportunity
-
- Pharmaceutical Prime Vendor Global GEN V Presolicitation Pre-Solicitation · SPE2DX24R0001 · Posted Feb 1, 2024
- Combined order value
- $69,200,513 Current and potential, with all options
- Last date to order 11% complete
- IDV ceiling 1% used
- $9,999,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Indefinite Delivery Contract (IDC) SPE2DR25D1106 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $9,999,999,999, will provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. The 11-year IDC, with a base period of 30 months and three 30-month option periods, covers an extensive array of medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This unrestricted, fully competitive acquisition aims to establish multiple Prime Vendor contracts to increase the DoD's resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract will utilize a Lowest Price Technically Acceptable evaluation criteria, with the possibility of a reverse auction to determine the final distribution fees.
The original solicitation, expected to be issued in March 2024, will cover medical pharmaceuticals in the 6505 stock catalog/schedule and the current National Drug Code (NDC) database. The Government intends to make multiple primary supplier awards for the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet regions, as well as a single award for a backup supplier covering all regions. This diversification strategy will ensure no single contractor receives an award for all the DoD's pharmaceutical requirements.
Task orders
Show 40 more
Latest 50 of 9,345 listed here. See the rest on GovTribe.
Quick answers
Who was awarded contract SPE2DR25D1106?
SPE2DR25D1106 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DR25D1106 worth?
Orders under SPE2DR25D1106 have obligated $69,200,513. SPE2DR25D1106's own ceiling is $9,999,999,999.
How many orders have been placed under contract SPE2DR25D1106?
9,345 orders have been placed under SPE2DR25D1106, the latest on July 31, 2026.
Who can order from contract SPE2DR25D1106?
SPE2DR25D1106 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DR25D1106 competed?
The extent of competition for SPE2DR25D1106 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV